Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL
· Real-Time Price · USD
1.31
-0.03 (-2.24%)
At close: Aug 15, 2025, 3:59 PM
1.31
-0.38%
After-hours: Aug 15, 2025, 04:39 PM EDT
Cardiol Therapeutics Balance Sheet Statement
Financials in CAD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 23.29M | 30.58M | 15.89M | 24.02M | 28.57M | 34.87M | 40.54M | 44.94M | 49.47M | 59.47M | 65.53M | 70.45M | 74.84M | 83.9M | 28.65M | 32.72M | 18M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | 61.88K | 61.88K | 61.88K | 61.88K | 61.88K | 61.57K | n/a | 61.57K | 61.57K | 61.51K | 61.51K | 61.51K |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | n/a | n/a | n/a | n/a | n/a |
Receivables | 346.69K | 361.62K | 266.71K | n/a | 317.11K | n/a | n/a | n/a | 408.16K | n/a | 154.12K | 403.62K | 486K | 407.13K | 385.37K | 113.52K | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | -289.6K | n/a | n/a | n/a | 339.05K | 339.05 | 339.05K | n/a | 339.05K | 339.05K | 17.97K |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | 279.87K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 25.27M | 31.67M | 17.28M | 25.88M | 30.64M | 36.15M | 42.45M | 46.65M | 52.11M | 61.44M | 67.76M | 73.62M | 78.73M | 87.14M | 30.94M | 35.92M | 20.21M |
Property-Plant & Equipment | 182.54K | 195.59K | 237.93K | 263.01K | 300.01K | 337.06K | 372K | 269.29K | 302.78K | 295.74K | 284.83K | 308.91K | 339.45K | 356.49K | 390.97K | 412.54K | 446.05K |
Goodwill & Intangibles | n/a | n/a | n/a | 168.14K | 189.25K | 210.36K | 231.47K | 252.58K | 273.69K | 294.8K | 315.91K | 337.02K | 358.13K | 379.25K | 400.36K | 421.47K | 442.58K |
Total Long-Term Assets | 182.54K | 195.59K | 237.93K | 431.14K | 489.25K | 547.41K | 603.47K | 521.87K | 576.47K | 590.54K | 600.74K | 645.93K | 697.58K | 735.74K | 791.33K | 834K | 888.62K |
Total Assets | 25.45M | 31.86M | 17.52M | 26.31M | 31.13M | 36.7M | 43.05M | 47.17M | 52.69M | 62.03M | 68.36M | 74.26M | 79.43M | 87.88M | 31.73M | 36.75M | 21.1M |
Account Payables | 7.72M | 6.98M | 6.92M | 9.43M | 8.44M | 7.62M | 6.91M | 6.68M | 5.94M | 8.35M | 6.91M | 6.72M | 4.94M | 4.14M | 1.74M | 2.21M | 2.18M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -7.62M | 280.33K | -6.68M | -5.94M | -8.35M | -6.92M | -6.72M | -4.95M | -4.19M | -1.74M | -2.21M | -2.18M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | -280.33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | n/a | 3.65K | 1.36M | 2.05M | 238.18K | 529.5K | 1.2M | 345.82K | 419.9K | 1.94M | 3.67M | 4.53M | 6.66M | n/a | n/a | 0.00 |
Total Current Liabilities | 7.75M | 7.01M | 6.95M | 10.81M | 10.92M | 8.3M | 8.03M | 8.42M | 7.12M | 9.8M | 9.65M | 11.37M | 10.16M | 11.57M | 2.57M | 2.93M | 2.76M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 116.41K | 125.52K | 134.2K | 142.55K | 150.66K | 158.53K | 152.14K | n/a | 9.09K | 22.42K | 35.45K | 48.19K | 60.66K | 72.87K | 74.56K | 85.25K | 95.19K |
Total Liabilities | 7.87M | 7.14M | 7.09M | 10.95M | 11.07M | 8.45M | 8.18M | 8.42M | 7.13M | 9.83M | 9.68M | 11.41M | 10.22M | 11.64M | 2.65M | 3.01M | 2.86M |
Total Debt | 150.66K | 158.53K | 165.98K | 164.27K | 167.14K | 174.34K | 181.21K | 48.19K | 60.66K | 72.87K | 84.77K | 96.4K | 107.24K | 117.58K | 127.63K | 137.46K | 147.1K |
Common Stock | 179.34M | 179.34M | 154.63M | 152.35M | 151.09M | 148.52M | 147.77M | 147.67M | 147.63M | 147.55M | 146.93M | 143.14M | 143.05M | 142.92M | 89.83M | 85.53M | 67.75M |
Retained Earnings | -187.54M | -179.25M | -171.7M | -158.35M | -151.76M | -142.58M | -134.94M | -129.01M | -121.54M | -114.45M | -106.93M | -98.96M | -92.47M | -83.52M | -77.26M | -67.35M | -60.79M |
Comprehensive Income | n/a | n/a | n/a | n/a | 3.52M | 3.52M | 3.52M | 3.52M | 3.52M | 3.52M | 3.52M | 5.53M | 4.91M | 4.18M | 4.32M | 5.09M | 1.55M |
Shareholders Equity | 17.59M | 24.73M | 10.43M | 15.36M | 20.06M | 28.25M | 34.87M | 38.75M | 45.56M | 52.2M | 58.68M | 62.85M | 69.21M | 76.24M | 29.09M | 33.74M | 18.24M |
Total Investments | n/a | n/a | n/a | n/a | n/a | 61.88K | 61.88K | 61.88K | 61.88K | 61.88K | 61.57K | n/a | 61.57K | 61.57K | 61.51K | 61.51K | 61.51K |